DL PHARMA +
The computed 12-month bankruptcy probability of DL PHARMA + is 3.8% (moderate). The 2022 annual accounts show equity of €15k and a net result of €10k. The company has been active since 2020 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €15k |
| Net result | €10k |
| Active | 5 yrs |
| Locations | 1 |
Exceptional profile, strong across almost every axis.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.
See plans →| Fiscal year | 2022 |
|---|---|
| Revenue | - |
| EBITDA | €13k |
| Net profit | €10k |
| Cash flow | €10k |
| Staff costs | - |
| Income taxes | €3k |
| Dividends | - |
| Total assets | €28k |
| Equity | €15k |
| Debt | €13k |
| of which ≤ 1y | €13k |
| of which > 1y | - |
| Working capital | €14k |
| Employees (FTE) | - |
| 2022 | |
|---|---|
| Current ratio | 2.07 |
| Quick ratio | 2.07 |
| Working capital ratio | 51.4% |
| Solvency | 52.1% |
| Debt / equity | 0.92 |
| Long-term debt ratio | - |
| Interest coverage | 85.96 |
| Gross margin | - |
| Net margin | - |
| ROA | 34.4% |
| ROE | 65.9% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2022 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €28k |
| Fixed assets | 21/28 | €194 |
| Tangible fixed assets | 22/27 | €194 |
| Current assets | 29/58 | €28k |
| Amounts receivable within one year | 40/41 | €6k |
| Cash & bank | 54/58 | €21k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €28k |
| Equity | 10/15 | €15k |
| Contributions / capital | 10/11 | €5k |
| Reserves | 13 | €10k |
| Amounts payable | 17/49 | €13k |
| Amounts payable within one year | 42/48 | €13k |
| Trade debts payable within one year | 44 | €2k |
| Income statement | ||
| Gross operating margin | 9900 | €13k |
| Operating result | 9901 | €12k |
| Financial charges | 65 | €146 |
| Result before taxes | 9903 | €12k |
| Income taxes | 67/77 | €3k |
| Net result for the period | 9904 | €10k |
| Result to be appropriated | 9905 | €10k |
| NACE primary | Retail trade(47730) |
| Legal form | Private limited company(610) |
| Incorporation | 28-09-2020 |
| Status | Active |
| Postal code | 9870 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 44050B0812/00A000 | Flanders | 2,535 m² | 1 · 157 m² | 7.8 m · 1 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
19-12-2025 Registered office moved within Zulte
- Olsenestraat 148, 9870 Zulte → Boswegel 27, 9870 Zulte
Technical details
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "statutaire",
"new_address": {
"city": "Zulte",
"region": null,
"street": "Boswegel",
"country": "BE",
"postcode": "9870",
"box_number": null,
"street_number": "27"
},
"old_address": {
"city": "Zulte",
"region": null,
"street": "Olsenestraat",
"country": "BE",
"postcode": "9870",
"box_number": null,
"street_number": "148"
},
"effective_date": "2025-12-19",
"evidence_quote": "wordt door het bestuursorgaan besloten om de maatschappelijke zetel van de vennootschap vanaf heden te verplaatsen van Olsenestraat 148, 9870 Zulte naar Boswegel 27, 9870 Zulte."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0755.325.637",
"name_full": "DL PHARMA \u002B",
"legal_form": "BV"
}
}30-09-2020 Incorporation of a new BV
Technical details
{
"kind": "oprichting",
"seat": "9870 Zulte, Olsenestraat 148",
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"founders": [
{
"org": null,
"kind": "natural_person",
"person": {
"dob": null,
"name": "DE LOENZIEN Elke Cecile Jo\u00EBl",
"niss": null,
"address": "9870 Zulte, Olsenestraat 148"
},
"share_class": "Ordinary",
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": null,
"contribution_type": "cash",
"amount_paid_in_eur": 5000,
"holder_person_name": "DE LOENZIEN Elke Cecile Jo\u00EBl",
"is_subscriber_only": false,
"n_shares_subscribed": 100,
"amount_subscribed_eur": 5000,
"is_anonymous_silent_partner": false
}
],
"capital_eur": 5000,
"subject_company": {
"kbo": "0755.325.637",
"name_full": "DL PHARMA \u002B",
"legal_form": "BV"
},
"initial_directors": [],
"incorporation_date": "2020-09-24",
"post_incorporation_mandates": []
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameNL | DL PHARMA + |